Cargando…
Microbe‐Derived Butyrate and Its Receptor, Free Fatty Acid Receptor 3, But Not Free Fatty Acid Receptor 2, Mitigate Neointimal Hyperplasia Susceptibility After Arterial Injury
BACKGROUND: Arterial restenosis after vascular surgery is a common cause of midterm restenosis and treatment failure. Herein, we aim to investigate the role of microbe‐derived butyrate, FFAR2 (free fatty acid receptor 2), and FFAR3 (free fatty acid receptor 3) in mitigating neointimal hyperplasia de...
Autores principales: | Nooromid, Michael, Chen, Edmund B., Xiong, Liqun, Shapiro, Katherine, Jiang, Qun, Demsas, Falen, Eskandari, Maeve, Priyadarshini, Medha, Chang, Eugene B., Layden, Brian T., Ho, Karen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670501/ https://www.ncbi.nlm.nih.gov/pubmed/32580613 http://dx.doi.org/10.1161/JAHA.120.016235 |
Ejemplares similares
-
FRI013 Free Fatty Acid Receptors 2 And 3 Mediate The Beneficial Effects Of Fiber
por: Pandya, Nupur S, et al.
Publicado: (2023) -
Endogenously Generated Omega‐3 Fatty Acids Attenuate Vascular Inflammation and Neointimal Hyperplasia by Interaction With Free Fatty Acid Receptor 4 in Mice
por: Li, Xinzhi, et al.
Publicado: (2015) -
Loss of Free Fatty Acid Receptor 2 leads to impaired islet mass and beta cell survival
por: Villa, Stephanie R., et al.
Publicado: (2016) -
Vancomycin treatment and butyrate supplementation modulate gut microbe composition and severity of neointimal hyperplasia after arterial injury
por: Ho, Karen J., et al.
Publicado: (2015) -
Editorial: Free Fatty Acids as Signaling Molecules: Role of Free Fatty Acid Receptors and CD36
por: Puebla, Carlos, et al.
Publicado: (2022)